| Acquired by | MEDRAD |
| Date | 9/11 |
| Website | pathwaymedical.com |
| Category | BioTech |
| Employees | |
| Description | arterial diseases devices |
| Series D, 3/09 Forbion Capital Partners HLM Venture Partners Latterell Venture Partners Oxford Bioscience Partners Giza Venture Capital | $42.5M |
Pathway Medical Technologies, Inc. was founded to develop, manufacture and market medical devices for the treatment of arterial disease. The company’s initial focus is treating peripheral arterial disease (PAD) more quickly, safely and effectively than existing technologies.
